Adverse Event Reporting
Adverse Event Reporting in Korea Is Not Optional — and the Clock Starts Immediately.
Your global PMS process does not satisfy MFDS vigilance requirements.
Global pharmacovigilance procedures do not cover Korea. MFDS requires adverse event reports in Korean through designated channels, within 15 days for serious events.

Continuous Signal Monitoring
We maintain an active watch on adverse event complaints, field safety signals, and post-market feedback routed through your organization, capturing every event that may trigger an MFDS reporting obligation.

MFDS-Compliant Report Submission
We prepare and submit adverse event reports in Korean, through the correct MFDS reporting channel, within the mandatory 15-day (serious) or 30-day (non-serious) windows — with zero missed deadlines.

Follow-Up and CAPA Coordination
Where MFDS requires follow-up reports or corrective action documentation, we coordinate with your global quality team to prepare the required Korean-format response and close the loop with the agency.
What You Receive
Leanabl provides a complete, audit-ready vigilance record and regular structured reporting to your global quality team.
Frequently Asked Questions
Common questions about MFDS adverse event reporting obligations and how Leanabl's Vigilance subscription operates.
One Missed Report Can Suspend Your Entire Korean Product Portfolio.
A single unreported serious event — even when correctly reported under EU MDR — can trigger sales suspension. Subscription-based, permanently active Korea-qualified vigilance from day one.
Activate Your MFDS Vigilance Coverage Now